Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0LL1F
|
||||
| Former ID |
DNC011264
|
||||
| Drug Name |
[2-Phenylacetophenone]thiosemicarbazone
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [531200] | ||
| Formula |
C15H15N3S
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)CC(=NNC(=S)N)C2=CC=CC=C2
|
||||
| InChI |
1S/C15H15N3S/c16-15(19)18-17-14(13-9-5-2-6-10-13)11-12-7-3-1-4-8-12/h1-10H,11H2,(H3,16,18,19)/b17-14+
|
||||
| InChIKey |
WHRFFXUXTGIZOH-SAPNQHFASA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Cathepsin L | Target Info | Inhibitor | [531200] | |
| NetPath Pathway | IL4 Signaling Pathway | ||||
| TGF_beta_Receptor Signaling Pathway | |||||
| WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.